{
    "id": 28274,
    "fullName": "PARP1 K119_S120del",
    "impact": "deletion",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PARP1 K119_S120del results in the deletion of two amino acids in the PARP-type zinc finger domain 2 of the Parp1 protein (UniProt.org). K119_S120del results in a loss of recruitment of Parp1 to DNA damage sites and is associated with resistance to PARP inhibitors in cell culture (PMID: 29748565), and therefore, is predicted to lead to a loss of Parp1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11365,
                    "pubMedId": 29748565,
                    "title": "Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29748565"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 142,
        "geneSymbol": "PARP1",
        "terms": [
            "PARP1",
            "ADPRT",
            "ADPRT 1",
            "ADPRT1",
            "ARTD1",
            "pADPRT-1",
            "PARP",
            "PARP-1",
            "PPOL"
        ]
    },
    "variant": "K119_S120del",
    "createDate": "05/18/2018",
    "updateDate": "08/07/2019",
    "referenceTranscriptCoordinates": {
        "id": 178482,
        "transcript": "NM_001618",
        "gDna": "chr1:g.226392243_226392248delACTTGG",
        "cDna": "c.357_362delGTCCAA",
        "protein": "p.K119_S120delKS",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13926,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ovarian cancer cells harboring two BRCA1 mutations and expressing PARP1 K119_S120del demonstrated resistance to treatment with Talazoparib (BMN-673) in culture (PMID: 29748565).",
            "molecularProfile": {
                "id": 29874,
                "profileName": "BRCA1 mut PARP1 K119_S120del"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 11365,
                    "pubMedId": 29748565,
                    "title": "Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29748565"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29867,
            "profileName": "PARP1 K119_S120del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29874,
            "profileName": "BRCA1 mut PARP1 K119_S120del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178482,
            "transcript": "NM_001618",
            "gDna": "chr1:g.226392243_226392248delACTTGG",
            "cDna": "c.357_362delGTCCAA",
            "protein": "p.K119_S120delKS",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}